Advertisement

PentaVision

Glaucoma Physician

Article

A New Challenge—and Opportunity—in Glaucoma

From the Editor: The way that surgeons present the disease and its treatments can help patients achieve their best outcomes.

Nathan M. Radcliffe, MD
Glaucoma Physician September 1, 2025 Page(s): 1

Clinical Scorecard: A New Challenge—and Opportunity—in Glaucoma

At a Glance

CategoryDetail
ConditionGlaucoma
Key MechanismsIntraocular pressure management and outflow system treatment
Target PopulationPatients diagnosed with glaucoma
Care SettingOphthalmology clinics and surgical centers

Key Highlights

  • Topical eye drops can significantly decrease quality of life for glaucoma patients.
  • Patients often perceive topical medications as benign and manageable.
  • New interventions like MIGS and sustained delivery can replace topical therapy.
  • Emphasis on the side effects of long-term topical therapy is crucial.
  • Advances in diagnostics may enhance individualized treatment approaches.

Guideline-Based Recommendations

Diagnosis

  • Accurately communicate disease stage, velocity, and prognosis.

Management

  • Consider MIGS and sustained delivery as alternatives to topical therapy.

Monitoring & Follow-up

  • Tailor discussions on glaucoma treatment to individual patient needs.

Risks

  • Highlight potential side effects of topical therapy, including cataract formation and dry eye.

Patient & Prescribing Data

Individuals with varying stages of glaucoma.

Motivating patients to accept early intervention therapies is essential.

Clinical Best Practices

  • Reset the introduction of glaucoma and treatment options for patients.
  • Focus on the direct treatment of the diseased meshwork.

References